Cargando…
Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers
The interactions of chemotherapeutic drugs with nanocage protein apoferritin (APO) are the key features in the effective encapsulation and release of highly toxic drugs in APO-based controlled drug delivery systems. The encapsulation enables mitigating the drugs’ side effects, collateral damage to h...
Autores principales: | Kurzątkowska, Katarzyna, Pazos, Manuel A., Herschkowitz, Jason I., Hepel, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866407/ https://www.ncbi.nlm.nih.gov/pubmed/33572999 http://dx.doi.org/10.3390/ijms22031362 |
Ejemplares similares
-
Glioma targeting peptide modified apoferritin nanocage
por: Zhai, Meifang, et al.
Publicado: (2018) -
Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine
por: Santiago, Ty, et al.
Publicado: (2017) -
Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity
por: Ji, Peng, et al.
Publicado: (2022) -
Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy
por: Yao, Hanchun, et al.
Publicado: (2016) -
Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery
por: Blazkova, Iva, et al.
Publicado: (2013)